Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2020 Nov 25;62(4):1039. doi: 10.1111/epi.16767

Corrigendum

PMCID: PMC8173635  PMID: 33836101

In Table 3 of the article by Ben‐Menachem et al, 1 in the row labeled “Any TEAEs,” the value under column heading “LCM (n = 157)” was incorrect, the value under column heading “CBZ‐CR (n = 148)” was mistakenly omitted. The correct version of this row within the table is provided below:

graphic file with name EPI-62-1039-g001.jpg

We apologize for this error.

. Corrigendum. Epilepsia.2021;62:1039–1039. 10.1111/epi.16767

REFERENCE

  • 1. Ben‐Menachem E, Grebe HP, Terada K, Jensen L, Li T, De Backer M, et al. Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy. Epilepsia. 2019;60(12):2437–47. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Epilepsia are provided here courtesy of Wiley

RESOURCES